Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segments (Tables)

v3.3.0.814
Schedule of Segments (Tables)
9 Months Ended
Sep. 30, 2015
Schedule of Segments (Tables)  
Schedule of Segment Reporting Information, by Segment

The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below. 

 

 

Cannabis and Medical Marijuana Segment

Trash Management

Corporate unallocated and Eliminations

Consolidated

Three Months ended September 30, 2015

 

Net sales

$

33,156

$

636,107

$

-

$

669,263

Income from operations

 

7,355

11,516

(204,264)

(185,393)

Interest income

 

3,346

-

23,821

27,167

Interest expense

 

649

4,881

(1,384)

4,146

Depreciation and amortization

 

386

7,564

1,197

9,147

 

Three Months ended September 30, 2014

 

Net sales

$

1,600

$

544,615

$

-

$

546,215

Income from operations

 

(4,070)

41,646

(207,704)

(170,128)

Interest income

 

-

-

12,453

12,453

Interest expense

 

-

7,043

-

7,043

Depreciation and amortization

 

-

4,917

946

5,863

 

Nine Months ended September 30, 2015

 

Net sales

$

63,465

$

1,808,035

$

-

$

1,871,500

Income from operations

 

200

92,103

(665,134)

(572,831)

Interest income

 

5,814

-

42,040

47,854

Interest expense

 

987

14,660

(3,442)

12,205

Depreciation and amortization

 

830

21,184

2,564

24,578

 

Nine Months ended September 30, 2014

 

Net sales

$

2,550

$

1,543,578

$

-

$

1,546,128

Income from operations

 

(37,770)

154,943

(698,261)

(581,088)

Interest income

 

-

-

15,982

15,982

Interest expense

 

-

13,454

96

13,550

Depreciation and amortization

 

-

17,100

2,214

19,314

 

Total assets:

 

September 30, 2015

$

2,335,005

$

1,097,137

$

1,600,357

$

5,018,254

September 30, 2014

 

1,541,533

2,553,400

1,443,834

5,538,767